Innovative imaging technology promises improved cardiac care Leading global experts in interventional cardiology recently participated and shared their breaking clinical trials, researches,…
SMT’s Supraflex stent clinically at par with Abbott’s Xience , with numerically better outcome:… Patients who got Supraflex stent had target lesion failure occur among 6.9 per cent at 720 days vs 7.9 per cent of Xience…
